Transplantation

Two Patents Issued for "Universal Donor Cell" Development

Published in Cancer Weekly, June 12th, 1995

Cell Genesys, Inc., Foster City, California, announced that the U.S. Patent Office has issued two patents assigned to the company related to its research program to create "universal donor" cells.

Universal donor cells are cells genetically modified to avoid tissue rejection following transplantation and represent a potential approach to in vivo gene therapy for diseases such as viral infection and cancer.

The two patents issued to Cell Genesys concern genetic modifications which may be used to create certain types of universal donor cells. One of the patents covers human epithelial cells such as skin and eye cells carrying a specific genetic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-06-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry